Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Abstract Text:

Takeki Suzuki,Shunichi Homma,Takeki Suzuki,Shunichi Homma,Takeki Suzuki,Shunichi Homma,

Metabolic syndrome (MetS), a concurrence of hypertension, abdominal obesity, impaired fasting glucose, and dyslipidemia, has been shown to be a risk factor for cardiovascular disease. Insulin resistance has been thought to be one of the pathophysiologies of the syndrome. Reduction of the underlying causes of MetS, such as obesity, physical inactivity, and atherogenic diet, is first-line therapy. Treatment of hypertension and other cardiometabolic risk factors of MetS is also required. This article reviews the treatment of the metabolic syndrome with a focus on the importance of lifestyle changes and treatment of hypertension.

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Publishing Authors By Initials

T Suzuki,S Homma,T Suzuki,S Homma,T Suzuki,S Homma,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Medical clinics of North America

VOLUME: 91

Page Numbers: 1211-23

Journal Abbreviation: Med. Clin. North Am.

ISSN: 0025-7125

DAY: 29

MONTH: Nov

YEAR: 2007

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985236

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.

AFFILIATION: Division of Cardiology, Department of Medicine, University of Vermont College of Medicine, 111 Colchester Avenue, Burlington, VT 05403, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Med Clin North Am

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome Related Publications

• A simple and effective treatment for stuttering: Speech practice without audience.
• A unique loop contributing to the structure of the ATP-binding cleft of skeletal muscle myosin communicates with the actin-binding site.
• Biochemistry of D-aspartate in mammalian cells.
• Characterization of a flagellar sheath component, PF60, and its structural gene in marine Vibrio.
• Characterization of circulating DNA in healthy human plasma.
• Cloning and characterization of motX, a Vibrio alginolyticus sodium-driven flagellar motor gene.
• Conformational changes in the unique loops bordering the ATP binding cleft of skeletal muscle myosin mediate energy transduction.
• Dynamic cardiac information from optical flow using four dimensional ultrasound.
• Effects of ultrasonic exposure parameters on myocardial lesions induced by high-intensity focused ultrasound.
• Essential regions of the lipopolysaccharide of Pseudomonas aeruginosa responsible for pyrogenicity and activation of the proclotting enzyme of horseshoe crabs. Comparison with antitumor, interferon-inducing and adjuvant activities.
• Flagellin-containing membrane vesicles excreted from Vibrio alginolyticus mutants lacking a polar-flagellar filament.
• Impact of valvular thickness on stroke recurrence in medically treated patients with stroke.
• Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program.
• Inhibition of phosphoinositide hydrolysis and cell growth of Swiss 3T3 cells by myristoylated phospholipase C inhibitor peptides.
• Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis.
• Lower urinary tract symptomatology: Its definition and confusion.
• Molecular cloning of a cDNA encoding mouse D-aspartate oxidase and functional characterization of its recombinant proteins by site-directed mutagenesis.
• Morphological Approach for the Functional Improvement of an Artificial Myocardial Assist Device using Shape Memory Alloy Fibres.
• Multimeric structure of the PomA/PomB channel complex in the Na+-driven flagellar motor of Vibrio alginolyticus.
• On the isolation of antigenic substances from Pseudomonas aeruginosa.
• Pneumoperitoneum recurring concomitantly with asthmatic exacerbation.
• Quantitative in silico analysis of the selectivity of graphitic carbon synthesized by different methods.
• Re: Validation of the overactive bladder symptom score J. G. Blaivas, G. Panagopoulos, J. P. Weiss And C. Somaroo J Urol 2007; 178: 543-547.
• Regulation of polar flagellar number by the flhF and flhG genes in Vibrio alginolyticus.
• Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
• Two modes of respiratory rhythm generation in the newborn rat brainstem-spinal cord preparation.
• [Diagnosis of extrauterine pregnancy from curettage materials.]
• [Not Available.]
• [Not Available.]
• [The role of isomerized protein repair enzyme, PIMT, in cellular functions]